Search for: "Lupin Pharmaceuticals"
Results 121 - 140
of 175
Sort by Relevance
|
Sort by Date
17 Feb 2010, 5:10 am
King Pharmaceuticals Inc. et al (Patent Docs) Famvir (Famciclovir) – US: Teva and Novartis settle patent litigation regarding Famciclovir (IP Factor) (SmartBrief) Gardasil, Silgard - Portugal: More on Gardasil and Silgard from Portugal (SPC Blog) Lipitor (Atorvastatin) – Philippines: UniLab can still sell generic version of Pfizer's Lipitor after a Makati court denies latter's petition for preliminary injunction (GenericsWeb) Mucinex (Guaifenesin) – US: W D… [read post]
10 Feb 2010, 4:47 pm
Lupin Pharmaceuticals, Inc. et al. [read post]
9 Feb 2010, 8:35 pm
• Defendants: Lupin, Ltd.; Lupin Pharmaceuticals, Inc. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
21 Jan 2010, 1:00 am
Lupin, Ltd. et al. [read post]
9 Dec 2009, 3:59 pm
Lupin Pharmaceuticals, Inc. et al. [read post]
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs) Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat) Famvir (Famciclovir) – US: New Jersey… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
9 Oct 2009, 9:11 am
Lupin Limited and Lupin Pharmaceuticals Inc. [read post]
21 Sep 2009, 2:30 am
Patent No. 5,023,269) covers a pharmaceutical composition including a selective serotonin and norepinepherine reuptake inhibitor (SSNRI). [read post]
13 Sep 2009, 9:31 pm
LLC • Defendants: Lupin Limited; Lupin Pharmaceuticals Inc. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs) Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
3 Jun 2009, 8:55 pm
The Eastern District of Virginia construed the claims and granted-in-part Lupin's motion for summary judgment of noninfringement, In the Illinois action, Abbott sued Sandoz (and Sandoz GmbH, Teva Pharmaceuticals, Ranbaxy Laboratories, Par Pharmaceutical) for infringement after they wanted to market generic versions of Omnicef. [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
11 May 2009, 9:03 am
Lupin settlement agreement is quite similar to Wyeth’s earlier settlement agreements with Impax Labs and Anchen Pharmaceuticals for the same drug. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences (Managing… [read post]
